*EU DRUG REGULATOR SAYS ASTRAZENECA SHOT BENEFIT OUTWEIGHS RISK— zerohedge (@zerohedge) April 7, 2021
*EU DRUG REGULATOR SAYS ASTRAZENECA SHOT BENEFIT OUTWEIGHS RISK